วันศุกร์ที่ ๙ ธันวาคม พ.ศ. ๒๕๕๙ ๒๐:๒๙ น.
Food and Healthcare Press Releases
Forgetting someone's name, not remembering where you parked the car, misplacing your phone or forgetting why you came into the kitchen – these are very common memory lapses we experience from time to time. But more and more, these moments don't
Eli Lilly and Company (NYSE:LLY) today presented detailed results of its phase 3 EXPEDITION3 trial at the 9th Clinical Trials on Alzheimer's Disease (CTAD) meeting. As previously disclosed, solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a study of solanezumab initiated in people with mild dementia due to Alzheimer's disease (AD), and Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to AD.
"The results of EXPEDTION3 are without question disappointing," said Eric Siemers, M.D., distinguished medical fellow at Lilly. "However, Lilly remains committed to finding solutions for this devastating disease. We will continue to analyze study results and work with the external scientific community in the hopes of uncovering findings that will help shape and advance future Alzheimer's disease research."
"Alzheimer's is a challenging disease that researchers have been committed to studying for some years," Dr. Honig said. "Now is not the time to give up. While the outcome of this study is not what we had hoped for, it is reasona
Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its customisable SureSeq(TM) NGS panel range with the launch of the SureSeq myPanel(TM) NGS Custom FH Panel - allowing fast and cost-effective study of variants in familial
Clinically proven and cost effective solution for gastroesophageal reflux disease recently launched in China. Mederi Therapeutics Inc. has announced regulatory approval by CFDA and product launch in China for Stretta Therapy, a non-surgical treatment
Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today's award by the United States Department of Energy's (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative
- Innovation and digital presence identified as main drivers of successful engagement with consumers and healthcare professionals Merck, a leading science and technology company, has developed a novel approach to product co-creation for its Consumer
Novo Nordisk today announced that NovoSeven(R) (rFVIIa), a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds when initiated within one hour after onset of bleeding, demonstrating efficacy of early treatment in
Novo Nordisk today announced new phase 3b trial (DUAL VII) results with Xultophy(R) (IDegLira). Xultophy(R) is a once-daily, single injection fixed combination of a long-acting basal insulin (insulin degludec) and a glucagon-like peptide-1 (GLP-1)
bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company's newest product, the INSTI HIV Self Test, to Kenya's Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905
bioLytical Laboratories (the "Company"), a world leader in rapid infectious disease tests, announced today it is expanding the launch of its INSTI HIV Self Test to Africa with a lower cost version starting this month. Photo -
- Merck to be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and quantitative real-time PCR, for all countries except the U.S., Brazil and Japan - Exclusive global distributor for Roche's biochemical reagents portfolio since
GSK has today been ranked first in the Access to Medicine Index for the fifth consecutive time, taking a leadership position in research & development; pricing, manufacturing and distribution of medicines; and product donations. The Index, which
-- The International Phenome Centre Network (IPCN) of leading global research institutions works to transform healthcare through phenomics - the dynamic interactions between our genes and our environment. -- Phenomics can advance precision medicine
- If approved by the FDA, avelumab, an investigational immunotherapy, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma (MCC) - Avelumab has previously received FDA Breakthrough Therapy and Fast Track Designations
In celebration of #GivingTuesday and the holiday giving season, Smile Train , the world's largest cleft organization, launched its new " Give Smiles " campaign today to help more children around the world smile and live happier, healthier lives. From
Idopathic Pulmonary Fibrosis (IPF) is a debilitating and fatal lung disease that currently affects approximately 3 million people worldwide with a median survival of 2-3 years after diagnosis (1)(2). It is a silent killer that many are not aware of.
Eli Lilly and Company (NYSE: LLY) today announced that solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a phase 3 study of solanezumab in people with mild dementia due to Alzheimer's disease (AD). Patients treated with
Mederi Therapeutics Inc., manufacturers of Stretta Therapy for gastroesophageal reflux disease (GERD), announced the publication of a case series demonstrating the viability of Stretta Therapy as a treatment for chronic GERD after a Laparoscopic Sleeve
Highly integrated molecular genetics portfolio delivers significant revenue growth and sustainable profit Oxford Gene Technology (OGT), The Molecular Genetics Company has announced continued strong sales of its highly integrated molecular genetics
Healthcare Information and Management Systems Society (HIMSS) และ College of Health Information Management Executives (CHIME) บรรลุข้อตกลงเป็นพันธมิตรในทุกโครงการและทุกชุมชนผู้เชี่ยวชาญนอกอเมริกาเหนือ ภายใต้ชื่อ HIMSS-CHIME International
The Healthcare Information and Management Systems Society (HIMSS) and the College of Health Information Management Executives (CHIME) announced a pivotal agreement to jointly partner on all programs and professional communities outside of North America.
Quality Science Produced from Asian and other non-English speaking Countries is not getting cited and reaching the scientific fraternity. Dr. Srinubabu Gedela , CEO, OMICS International , said, open access journals are all set to break the supremacy
COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced deliverability OrbusNeich has announced the launch of its latest generation Dual Therapy Stent (DTS), the COMBO
Tillotts Pharma AG (Switzerland) introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The OPTICORE(TM) coating technology comprises two trigger systems